Randomized Phase III study of gemcitabine plus S-1 versus gemcitabine plus cisplatin in advanced biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1113, FUGA-BT)

A Phase II selection design trial was conducted to identify the most promising regimen for comparison with standard therapy in chemo-naive patients with unresectable or recurrent biliary tract cancer (JCOG0805). Gemcitabine plus S-1 therapy showed better efficacy than S-1 monotherapy with acceptable...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Jpn J Clin Oncol
Autores principales: Mizusawa, Junki, Morizane, Chigusa, Okusaka, Takuji, Katayama, Hiroshi, Ishii, Hiroshi, Fukuda, Haruhiko, Furuse, Junji
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2016
Materias:
Clinical Trial Note
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4886137/
https://ncbi.nlm.nih.gov/pubmed/27025903
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jjco/hyv213
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares